Skip to main content

Diabetes and Covid-19

New Content ItemSince the first reports of Covid-19 in Wuhan, China, research from all around the globe has confirmed the relationship between diabetes, hypertension and cardiovascular disease, and Covid-19 outcomes. The high frequencies of these comorbidities among hospitalized patients and in those with fatal outcome have shown their importance as risk factors for serious outcomes and lethality. 

In this Collection we publish research that investigates these relationships as well as treatment and prognosis, physiopathology, epidemiology and any other impact that Covid-19 may have on diabetic patients’ health.

Sergio Vencio and Marcello Bertoluci
Editor-in-Chief and Deputy Editor-in-Chief

Open for submissions. Check our submissions guidelines at the journal website.

Articles in the Collection

  1. Our understanding of the pathophysiology of the COVID-19 manifestations and evolution has improved over the past 10 months, but the reasons why evolution is more severe in obese and diabetic patients are not y...

    Authors: Andrey Santos, Daniéla Oliveira Magro, Rosana Evangelista-Poderoso and Mario José Abdalla Saad

    Citation: Diabetology & Metabolic Syndrome 2021 13:23

    Content type: Review

    Published on:

  2. A dysregulated host immune response is common in patients with COVID-19.

    Authors: Dafeng Liu, Yong Wang, Bennan Zhao, Lijuan Lan, Yaling Liu, Lei Bao, Hong Chen, Min Yang, Qingfeng Li and Yilan Zeng

    Citation: Diabetology & Metabolic Syndrome 2021 13:5

    Content type: Research

    Published on:

  3. The disclosure in the media of a benefit with the use of dexamethasone in patients with COVID-19 infection sets precedents for self-medication and inappropriate use of corticosteroids.

    Authors: Janine Alessi, Giovana B. de Oliveira, Beatriz D. Schaan and Gabriela H. Telo

    Citation: Diabetology & Metabolic Syndrome 2020 12:80

    Content type: Review

    Published on:

  4. In patients with diabetes, the prevalence of depression and anxiety symptoms is about two to four times greater than in the general population. The association between diabetes and mental health disorders coul...

    Authors: Janine Alessi, Giovana Berger de Oliveira, Debora Wilke Franco, Bibiana Brino do Amaral, Alice Scalzilli Becker, Carolina Padilla Knijnik, Gabriel Luiz Kobe, Taíse Rosa de Carvalho, Guilherme Heiden Telo, Beatriz D. Schaan and Gabriela Heiden Telo

    Citation: Diabetology & Metabolic Syndrome 2020 12:76

    Content type: Research

    Published on:

  5. The aim of this study is to evaluate the impact of diabetes, hypertension, cardiovascular disease and the use of angiotensin converting enzyme inhibitors/angiotensin II receptor blockers (ACEI/ARB) with severi...

    Authors: Bianca de Almeida-Pititto, Patrícia M. Dualib, Lenita Zajdenverg, Joana Rodrigues Dantas, Filipe Dias de Souza, Melanie Rodacki and Marcello Casaccia Bertoluci

    Citation: Diabetology & Metabolic Syndrome 2020 12:75

    Content type: Research

    Published on:

  6. Chronic inflammation is involved in the pathogenesis of several metabolic diseases, such as obesity and type 2 diabetes mellitus (T2DM). With the recent worldwide outbreak of coronavirus disease (SARS-CoV-2), ...

    Authors: Mauricio Krause, Fernando Gerchman and Rogério Friedman

    Citation: Diabetology & Metabolic Syndrome 2020 12:63

    Content type: Commentary

    Published on:

  7. Diabetes mellitus (DM) and cardiovascular disease (CVD) are present in a large number of patients with novel Coronavirus disease 2019 (COVID-19). We aimed to determine the risk and predictors of in-hospital mo...

    Authors: Hadith Rastad, Hossein Karim, Hanieh-Sadat Ejtahed, Ramin Tajbakhsh, Mohammad Noorisepehr, Mehrdad Babaei, Mehdi Azimzadeh, Alireza Soleimani, Seyed Hasan Inanloo, Neda Shafiabadi Hassani, Fariba Rasanezhad, Ehsan Shahrestanaki, Zeinab Khodaparast, Hossein Golami and Mostafa Qorbani

    Citation: Diabetology & Metabolic Syndrome 2020 12:57

    Content type: Research

    Published on:

\